Additionally, the expression of TFAM dropped in PBMCs derived from both AD and MCI patients.11 In addition, to the best of our knowledge, this is the first study reporting alterations in PGC1α, and TFAM levels in peripheral cells of parkinsonian patients. This evidence concerns the gene PPARGC1A and Alzheimer disease.